Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis

Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis

IntroductionNo prior meta-analysis has investigated the impact of programmed cell death protein 1 (PD-1) inhibitor therapy on survival outcomes in patients with advanced or recurrent uterine cancers (including both corpus and cervical cancers).MethodsA comprehensive search of PubMed and Embase datab...

Full description

Bibliographic Details
Main Authors:	Keng-Wei Liang, Liang-Jou Chen, Chun-Hao Wang, Kevin Sheng-Kai Ma, Li-Hsin Hsia, Po-Hui Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Immunology
Subjects:	uterine cancer PD-1 inhibitors survival adverse events meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1331994/full

Similar Items

Editorial: Assessment and management of adverse drug reactions in oncology
by: Ping-Feng Tsai, et al.
Published: (2023-07-01)

The Risk of Endometrial Cancer and Uterine Sarcoma Following Endometriosis or Pelvic Inflammatory Disease
by: Jing-Yang Huang, et al.
Published: (2023-01-01)

The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
by: I-Lun Hsin, et al.
Published: (2019-12-01)

Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases
by: E Sun Paik, et al.
Published: (2019-03-01)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
by: Myriam Gracia, et al.
Published: (2023-02-01)

Nivolumab plus ipilimumab versus nivolumab in individuals with treatment-naive programmed death-ligand 1 positive metastatic soft tissue sarcomas: a multicentre retrospective study
by: Yaolin Chen, et al.
Published: (2021-02-01)

Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation
by: Po-Han Lin, et al.
Published: (2019-08-01)

Epidemiology of medical adverse events: perspectives from a single institute in Taiwan
by: Chen-Hsu Wang, et al.
Published: (2016-06-01)

Long survival in a pancreatic carcinoma patient with multi-organ toxicities after sintilimab treatment: A case report
by: Chen-Xu Ni, et al.
Published: (2023-01-01)

Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry
by: Lina María Serna-Higuita, et al.
Published: (2021-12-01)

Oncological Safety of Diagnostic Hysteroscopy for Apparent Early-Stage Type II Endometrial Cancer: A Multicenter Retrospective Cohort Study
by: Hui Zhou, et al.
Published: (2022-06-01)

Uterine Niche: A Pathology to Consider
by: Francisca Mendes, et al.
Published: (2023-11-01)

Uterine Niche: A Pathology to Consider
by: Francisca Mendes, et al.
Published: (2023-11-01)

Uterine Niche: A Pathology to Consider
by: Francisca Mendes, et al.
Published: (2023-11-01)

Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
by: Yixi Zhang, et al.
Published: (2021-11-01)

Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
by: Yixi Zhang, et al.
Published: (2022-11-01)

Pulmonary Immune-Related Adverse Events of PD-1 Versus PD-L1 Checkpoint Inhibitors: A Retrospective Review of Pharmacovigilance
by: Ugochi Ebinama, et al.
Published: (2023-11-01)

Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience
by: Junjuan Xiao, et al.
Published: (2023-04-01)

Survival analysis of patients with rare tumors of the uterine corpus – carcinosarcoma
by: Stevanović Nemanja, et al.
Published: (2024-01-01)

Preliminary application of three-dimensional printing in congenital uterine anomalies based on three-dimensional transvaginal ultrasonographic data
by: Li Wang, et al.
Published: (2022-07-01)

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
by: Lihu Gu, et al.
Published: (2019-06-01)

An adverse event in a well-established cervical cancer screening program: an observational study of 19,000 females unsubscribed to the program
by: Larsen MB, et al.
Published: (2016-10-01)

A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand
by: Kulisara Nanthamongkolkul, et al.
Published: (2023-05-01)

The time window for the reversal of depigmentation from aggravation to recovery in a non-small-cell lung cancer patient with pre-existing vitiligo using anti-programmed cell death-1 therapy: A case report
by: Zhiru Gao, et al.
Published: (2022-08-01)

Effects of physicochemical factors on development and survival of Opisthorchis viverrini uterine eggs
by: Chanisala Sereewong, et al.
Published: (2018-01-01)

Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids – a systematic review and future perspectives
by: Jakub Kociuba, et al.
Published: (2023-12-01)

Adverse Events after Uterine Compression Sutures for Postpartum Hemorrhage: Report of Three Cases and Review of the Literature
by: Sevim Dinçer Cengiz, et al.
Published: (2016-04-01)

Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible
by: Xiaoting Ma, et al.
Published: (2023-11-01)

A study of uterine inertia on the spontaneous of labor using uterine electromyography
by: Pin Li, et al.
Published: (2021-05-01)

Mimicking uterine malignancy: Pelvic actinomycosis with giant uterine leiomyoma
by: Changzai Li, et al.
Published: (2021-01-01)

Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer
by: Charles A. Kunos, et al.
Published: (2023-07-01)

The clinical progression of patients with glioblastoma
by: Allison L. Hansen, et al.
Published: (2023-06-01)

A novel nomogram for predicting cancer-specific survival in women with uterine sarcoma: a large population-based study
by: Yuan-jie Li, et al.
Published: (2022-05-01)

Nanoparticle albumin‐bound paclitaxel in elder patients with advanced squamous non‐small‐cell lung cancer: A retrospective study
by: Yang Liu, et al.
Published: (2020-02-01)

Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials
by: Ibrahim Elmakaty, et al.
Published: (2023-05-01)

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma
by: Chung‐Wei Su, et al.
Published: (2023-03-01)

A case of uterine incarceration with unrecognized uterine torsion
by: Madison Kocher, MD, et al.
Published: (2020-10-01)

Recurrence of Uterine Rupture in a Pseudo-Unicornuate Uterus at 17 Weeks of Amenorrhea: Case Report and Literature Review
by: Banani A, et al.
Published: (2009-01-01)

Abnormal Uterine Bleeding Associated with Bupropion: A Case Report
by: Melek Kanarya Vardar, et al.
Published: (2022-09-01)

Effect of divergent selection for uterine capacity on embryonic survival and development at 30 h post-mating in unilaterally ovariectomized rabbit females
by: R. Peiro, et al.
Published: (2015-12-01)